About Veeva Systems Inc. Class A Common Stock (VEEV)
Veeva Systems Inc is a leading provider of cloud-based software solutions tailored specifically for the global life sciences industry. The company offers a range of products designed to streamline and enhance various aspects of the pharmaceutical and biotech sectors, including research and development, regulatory compliance, and commercial operations. By leveraging advanced technology and data analytics, Veeva enables life sciences organizations to improve their efficiency, accelerate drug development processes, and ensure adherence to regulatory standards, ultimately contributing to better patient outcomes and innovation in healthcare. Read More
Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) fell 10.6% in the afternoon session after the company reported third-quarter results that beat Wall Street's expectations, but the market seemingly hoped for more, focusing on a potential slowdown in future growth.
As November 2025 draws to a close, the financial markets are buzzing with activity, driven by a confluence of earnings reports, strategic partnerships, and shifting investor sentiment. Against a backdrop of evolving technological landscapes and consumer spending patterns, several prominent companies have emerged as significant stock movers, capturing the attention
Life sciences cloud software provider Veeva Systems (NYSE:VEEV) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 16% year on year to $811.2 million. Guidance for next quarter’s revenue was better than expected at $808.5 million at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $2.04 per share was 4.5% above analysts’ consensus estimates.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Over the past six months, Veeva Systems has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $297.36, representing a healthy 23.3% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Growth boosts valuation multiples, but it doesn’t always last forever.
Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
The stocks featured in this article have all approached their 52-week highs.
When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
Veeva Systems (VEEV) combines strong fundamentals with a bullish technical setup. This life sciences cloud leader shows robust earnings growth, no debt, and a positive chart formation.
